RxDoctor Payments Data

Jay Talsania, MD

Hand Surgery · Allentown, PANPI 1376535245

Payments from drug & device makers

$2,286in general payments, 2019–2025

Across 41 payments — averaging $55.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novus Surgical Consultants$1K
  • Arthrex$565
  • Stryker$269
  • Johnson & Johnson$113
  • Electronic Waveform Lab, Inc.$96
  • Axogen$46
  • plus $87 from 3 others

What the payments were for

  • Travel & lodging$1,01044%
  • Food & beverage$1,27756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novus Surgical Consultants16$1,112
Arthrex6$565
Stryker5$269
Johnson & Johnson1$113
Electronic Waveform Lab, Inc.7$96
Axogen2$46
Endo Pharmaceuticals Inc.2$36
Bioventus LLC1$33
Medartis Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,286 in reported general payments places this provider in the 40th percentile of 110 hand surgery providers in Pennsylvania.

See all hand surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$514,693
Medicare patients
1,048
Services billed
44,847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone65$366
Diclofenac Sodium14$256
Celecoxib20$238
Meloxicam110$227

Paid to pharmacies, not to this prescriber.

Other hand surgery in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →